Tissue Regenix Group (FRA:LSW) Total Assets: €40.91 Mil (As of Jun. 2025)


FRA:LSW Tissue Regenix Group PLC FRA:LSW
10 GF Score
Price €0.07
GF Value €0.84
! 5 Warning Signs
View Full Analysis

What is Tissue Regenix Group Total Assets?

Tissue Regenix Group FRA:LSW 10 Total Assets is €40.91 Mil as of Jun. 2025. GuruFocus rates FRA:LSW with a GF Score™ of 10/100 and a GF Value™ of €0.84. The stock has 5 warning signs investors should review.

Tissue Regenix Group's Total Assets for the quarter that ended in Jun. 2025 was €40.91 Mil.

During the past 12 months, Tissue Regenix Group's average Total Assets Growth Rate was 3.30% per year. During the past 3 years, the average Total Assets Growth Rate was 6.80% per year. During the past 5 years, the average Total Assets Growth Rate was 4.80% per year. During the past 10 years, the average Total Assets Growth Rate was 33.20% per year.

During the past 13 years, Tissue Regenix Group's highest 3-Year average Total Assets Growth Rate was 354.00%. The lowest was -86.10%. And the median was 41.10%.

Total Assets is connected with ROA %. Tissue Regenix Group's annualized ROA % for the quarter that ended in Jun. 2025 was -3.85%. Total Assets is also linked to Revenue through Asset Turnover. Tissue Regenix Group's Asset Turnover for the quarter that ended in Jun. 2025 was 0.28.

Tissue Regenix Group  (FRA:LSW) Total Assets Explanation

Total Assets is connected with ROA %.

Tissue Regenix Group's annualized ROA % for the quarter that ended in Jun. 2025 is

ROA %=Net Income (Q: Jun. 2025 )/( (Total Assets (Q: Dec. 2024 )+Total Assets (Q: Jun. 2025 ))/ count )
=-1.62/( (43.305+40.912)/ 2 )
=-1.62/42.1085
=-3.85 %

Note: The Net Income data used here is two times the semi-annual (Jun. 2025) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Tissue Regenix Group's Asset Turnover for the quarter that ended in Jun. 2025 is

Asset Turnover
=Revenue (Q: Jun. 2025 )/( (Total Assets (Q: Dec. 2024 )+Total Assets (Q: Jun. 2025 ))/ count )
=11.961/( (43.305+40.912)/ 2 )
=11.961/42.1085
=0.28

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Tissue Regenix Group Total Assets Related Terms

Tissue Regenix Group Total Assets Historical Data

* Premium members only.

The historical data trend for Tissue Regenix Group's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tissue Regenix Group Total Assets Chart

Tissue Regenix Group Annual Data
Trend Jan15 Jan16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Total Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 41.38 40.91 43.46 39.65 43.31

Tissue Regenix Group Semi-Annual Data
Jul15 Jan16 Jul16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 41.48 39.65 41.92 43.31 40.91
FRA:LSW
10GF Score
Tissue Regenix Group PLC FRA:LSW
Total Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Tissue Regenix Group Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Tissue Regenix Group's Total Assets for the fiscal year that ended in Dec. 2024 is calculated as

Total Assets=Total Equity (A: Dec. 2024 )+Total Liabilities (A: Dec. 2024 )
=27.748+15.557
=43.31

Tissue Regenix Group's Total Assets for the quarter that ended in Jun. 2025 is calculated as

Total Assets=Total Equity (Q: Jun. 2025 )+Total Liabilities (Q: Jun. 2025 )
=24.817+16.095
=40.91

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Assets →
What does a Total Assets of €40.91 Mil mean?
Tissue Regenix Group (FRA:LSW) has a Total Assets of €40.91 Mil as of Jun. 2025. The total amount of assets as recorded on a company's balance sheet. View historical data on Tissue Regenix Group and its competitors.
Is Tissue Regenix Group's Total Assets too high?
Tissue Regenix Group's current Total Assets is €40.91 Mil. Overall, Tissue Regenix Group has a GF Score™ of 10/100, reflecting its overall financial health beyond just this single metric.
How does Tissue Regenix Group's Total Assets compare to VRTX and REGN?
Tissue Regenix Group's Total Assets of €40.91 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Assets for a Biotechnology company?
A good Total Assets depends on the Biotechnology industry context. However, Total Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Assets mean?
A high Total Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets as recorded on a company's balance sheet. View historical data on Tissue Regenix Group and its competitors. Tissue Regenix Group's current Total Assets is €40.91 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tissue Regenix Group stock overvalued right now?
Tissue Regenix Group (FRA:LSW) has a current Total Assets of €40.91 Mil. The stock's GF Value™ is €0.84, compared to a current price of €0.07 — trading 91.7% below its estimated fair value. The current Total Assets is €40.91 Mil. Tissue Regenix Group's overall GF Score™ is 10/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Assets calculated?
Total Assets is calculated from a company's financial statements. For Tissue Regenix Group (FRA:LSW), the current Total Assets is €40.91 Mil as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Tissue Regenix Group (FRA:LSW) Overvalued in 2026?

Based on GuruFocus' analysis, Tissue Regenix Group stock appears to be undervalued. The current stock price of €0.07 is trading 91.7% below its estimated GF Value™ of €0.84.

Key valuation signals for FRA:LSW:

  • Total Assets: €40.91 Mil
  • GF Value™: €0.84 vs. price of €0.07 (91.7% below fair value)
  • GF Score™: 10/100 with 5 warning signs

No single metric tells the full story. See the FRA:LSW stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Tissue Regenix Group Business Description

Address Lotherton Way, Unit 3, Phoenix Court, Garforth, GBR, LS25 2GY
Tissue Regenix Group PLC is a pioneering medical technology company engaged in the development of regenerative products. The company incorporates dCELL and BioRinse technology, which helps to address complex and varying clinical needs. Its product portfolio includes Biosurgery, Orthopaedics, and Dental. The company has operations around the world, with special emphasis in the United States.
10GF Score

Get the complete analysis for FRA:LSW

Total Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.07
Price
€0.84
GF Value